Deep learning meets echocardiography — our AI parses ultrasound signals in real time, flagging structural defects the eye might miss. Early. Precise. Actionable.
Congenital heart disease affects roughly 1 in 100 live births, and early, accurate detection materially changes surgical outcomes. Most diagnostic AI in this space is trained to answer a narrow question in isolation: is this view normal or abnormal. We build the full pipeline instead, from raw echocardiography acquisition through view classification, structural measurement, and surgical outcome prediction, so a clinician gets a single coherent read rather than a stack of disconnected model outputs to reconcile themselves.
Our models are developed with clinicians trained at MIT and Harvard, published in peer-reviewed venues supported by the NIH and the American Heart Association, and validated against real surgical outcomes, not just retrospective image labels. That grounding matters in a clinical setting: a system used in fetal and perinatal cardiology has to be explainable to the physician making the call, auditable after the fact, and precise enough that its output changes a real decision rather than adding another dashboard to check.
The model identifies which echocardiographic view is being captured — A4C, PLAX, PSAX, subcostal — enabling downstream algorithms to apply view-specific analysis without operator labelling.
A segmentation model delineates all four chambers simultaneously — LV, RV, LA, RA — enabling precise automated measurement of volumes, wall thickness, and chamber dimensions throughout the cardiac cycle.
The diagnostic head runs multi-label classification across CHD types — ASD, VSD, Tetralogy of Fallot, hypoplastic left heart syndrome, coarctation of aorta — returning confidence scores and localised bounding boxes for each suspected defect.